SHARE
Platelet Rich Plasma Prp Market

Platelet Rich Plasma (PRP) Market Forecasts to 2028 - Global Analysis By Source (Homologous, Autologous), Application (Orthopedic and Spinal Surgery, Neurosurgery), End User, and By Geography

4.4 (90 reviews)
Published: July 2022 ID: SMRC21670
4.4 (90 reviews)
Published: July 2022 ID: SMRC21670

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Platelet Rich Plasma (PRP) Market is accounted for $618.74 million in 2022 and is expected to reach $1,343.88 million by 2028 growing at a CAGR of 13.8% during the forecast period. Platelet-rich plasma treatment uses the platelets by loading its concentration in the injection to improve the healing of different body parts. Platelet-rich plasma (PRP) is proven to be a prominent source of autologous products in the field of regenerative medicine and a true precursor for the healing process along with scaffold and stem cells.

Platelet-rich plasma therapy is witnessing a huge rise in its popularity and acceptance for treating arthritis as it inhibits inflammation, lessens the rate of progression of osteoarthritis, and develops the formation of new cartilage. According to the article published in the Lancet Journal in 2020, osteoarthritis affects 7% of the global population, more than 500 million people worldwide, with women disproportionately affected by the condition. The number of people affected globally rise by 48% from 1990 to 2019, and in 2019 osteoarthritis was the 15th highest cause of years lived with disability (YLDs) worldwide.

Market Dynamics:

Driver:

Increasing cosmetics surgery

The increasing incidence of sports injuries, an increase in the number of cosmetic and surgical treatments, and the increased utilization of platelet-rich plasma in various therapeutic sectors are all augmenting the market's rise. The number of treatments performed has expanded over the last five years, and people's demand for minimally invasive cosmetic surgery has grown across the United States. Liposuction and facelifts are becoming increasingly fashionable.

Restraint:

High prices of plasma therapy

A single platelet-rich plasma treatment will normally cost high. Treatments may need to be repeated at times. Platelet plasma therapy treatment costs vary depending on the provider and the number of injections needed. The cost of treatment varies relying upon its location, facilities, and the expertise of the specialist performing it.

Opportunity:

Technological advancements

Technological advancements in platelet-rich plasma devices have prompted an expansion in the utilization of pure platelet-rich plasma in different situations and with high platelet concentrations. The industry has additionally benefited from technological breakthroughs such as smart home diagnostic kits which are likely to provide ample opportunities for the market.

Threat:

FDA approval in end-use cases

Even though the equipment utilized to produce platelet rich plasma and the injections have been cleared by the FDA (Food and Drug Administration), this method is considered investigational and has not been officially approved by the FDA for some purposes. Outside of orthopedic treatment, platelet rich plasma is being utilized for the treatment of hair loss, skin rejuvenation, and post-surgical healing.

The orthopedic and spinal surgery segment is expected to be the largest during the forecast period

The orthopedic and spinal surgery segment is estimated to have a lucrative growth owing to the increasing number of orthopedic surgeries. As platelet rich plasma mimics the body’s natural healing process, companies in the platelet rich plasma market are tapping opportunities in orthopaedics and spinal surgeries.

The pure platelet rich plasma (P-PRP) segment is expected to have the highest CAGR during the forecast period

The pure platelet rich plasma (P-PRP) segment is anticipated to witness the fastest CAGR growth during the forecast period due to the benefits such as accelerated healing process, tissue repair and generation, improvement in overall function, and increased demand across distinct therapeutics industry spaces.

Region with highest share:

North America is projected to hold the largest market share during the forecast period due to the rising awareness about platelet rich plasma treatments, technological advancements, and the increasing number of cosmetics surgeries in the region. Moreover, the presence of supportive regulatory authorities is fuelling the market growth in North America.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to increasing number of cosmetic surgeries to improve facial features in countries, growing medical tourism industry and active involvement of academic and research institutes for evaluating the application of platelet rich plasma therapies.

Key players in the market

Some of the key players profiled in the Platelet Rich Plasma (PRP) Market include Zimmer Biomet Holdings Inc, Vertical Spine LLC, ThermoGenesis Holdings Inc, Arthrex Inc, Stryker Exactech Inc, Regen Lab, ISTO Biologics, Glofinn Oy, EmCyte Corporation, DePuy Synthes Companies, AdiStem Ltd, T-Biotechnology, Dr. PRP USA LLC and Royal Biologics.


Key Developments:

In Sep 2021, Royal Biologics announced FDA 510K approval of their Maxx™- PRP concentration system. Maxx™-PRP is a patented next generation concentration device that can be used to concentrate autologous whole blood, for the safe and rapid preparation of platelet rich plasma to use point of care for mixing with autograft and/or allograft to improve handling characteristics.

In July 2021, Zimmer Biomet Holdings Inc partnered with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. This partnership will allow Zimmer Biomet to provide our extensive network of orthopaedic surgeons with the option of patient-specific implants which are crafted with a combination of clinical and engineering expertise.

Sources Covered:
• Homologous
• Autologous
• Allogeneic

Products Covered:
• Pure Platelet-Rich Fibrin (P-PRF)
• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
• Platelet-Rich Plasma Instruments
• Leukocyte Rich Platelet Rich Plasma (L-PRP)
• Platelet Rich Plasma (PRP) Gel

Growth Factor Molecules Covered:
• Epidermal Growth Factor (EGF)
• Fibroblast Growth Factor-2 (FGF-2)
• Insulin-like Growth Factor (IGF)
• Platelet-Derived Growth Factor (PDGF)
• Vascular Endothelial Growth Factor (VEGF)

Applications Covered:
• Orthopedic and Spinal Surgery
• Sports Medicine
• Dermatology & Cosmetic Surgery
• Cardiac Muscle Injury
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Dentistry/Periodontal Surgery
• Aesthetics
• Nerve Injury
• Other Applications

End Users Covered:
• Academic & Research Institutes
• Hospitals
• Physician's office/Private Practice
• Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Platelet Rich Plasma (PRP) Market, By Source
5.1 Introduction
5.2 Homologous
5.3 Autologous
5.4 Allogeneic

6 Global Platelet Rich Plasma (PRP) Market, By Product
6.1 Introduction
6.2 Pure Platelet-Rich Fibrin (P-PRF)
6.3 Pure Platelet Rich Plasma (P-PRP)
6.4 Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
6.5 Platelet-Rich Plasma Instruments
6.6 Leukocyte Rich Platelet Rich Plasma (L-PRP)
6.7 Platelet Rich Plasma (PRP) Gel

7 Global Platelet Rich Plasma (PRP) Market, By Growth Factor Molecules
7.1 Introduction
7.2 Epidermal Growth Factor (EGF)
7.3 Fibroblast Growth Factor-2 (FGF-2)
7.4 Insulin-like Growth Factor (IGF)
7.5 Platelet-Derived Growth Factor (PDGF)
7.6 Vascular Endothelial Growth Factor (VEGF)

8 Global Platelet Rich Plasma (PRP) Market, By Application
8.1 Introduction
8.2 Orthopedic and Spinal Surgery
8.2.1 Arthritis
8.2.2 Chronic Tendinitis
8.2.3 Bone Repair and Regeneration
8.3 Sports Medicine
8.4 Dermatology & Cosmetic Surgery
8.4.1 Plastic Surgery
8.4.2 Androgenic Alopecia/Hair Care
8.4.3 Ulcer Healing
8.4.3.1 Venous Ulcer
8.4.3.2 Trophic Ulcer
8.4.3.3 Pyoderma Gangrenosum Ulcer
8.4.3.4 Vasculitic Ulcer
8.4.3.5 Traumatic Ulcer
8.4.3.6 Diabetic Ulcer
8.5 Cardiac Muscle Injury
8.6 Ophthalmic Surgery
8.7 Neurosurgery
8.8 General Surgery
8.9 Dentistry/Periodontal Surgery
8.10 Aesthetics
8.11 Nerve Injury
8.12 Other Applications
8.12.1 Wound Healing
8.12.2 Urology
8.12.3 Oral and Maxillofacial Surgery
8.12.4 Cardiothoracic Surgery

9 Global Platelet Rich Plasma (PRP) Market, By End User
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Hospitals
9.4 Physician's office/Private Practice
9.5 Clinics
9.5.1 Cosmetic/Dermatology/Trichology Clinics
9.5.2 Orthopedic Clinics
9.5.3 Ophthalmic Clinics

10 Global Platelet Rich Plasma (PRP) Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Zimmer Biomet Holdings Inc
12.2 Vertical Spine LLC
12.3 ThermoGenesis Holdings Inc
12.4 Arthrex Inc
12.5 Stryker Exactech Inc
12.6 Regen Lab
12.7 ISTO Biologics
12.8 Glofinn Oy
12.9 EmCyte Corporation
12.10 DePuy Synthes Companies
12.11 AdiStem Ltd
12.12 T-Biotechnology
12.13 Dr. PRP USA LLC
12.14 Royal Biologics

List of Tables
1 Global Platelet Rich Plasma (PRP) Market Outlook, By Region (2020-2028) ($MN)
2 Global Platelet Rich Plasma (PRP) Market Outlook, By Source (2020-2028) ($MN)
3 Global Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2020-2028) ($MN)
4 Global Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2020-2028) ($MN)
5 Global Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2020-2028) ($MN)
6 Global Platelet Rich Plasma (PRP) Market Outlook, By Product (2020-2028) ($MN)
7 Global Platelet Rich Plasma (PRP) Market Outlook, By Pure Platelet-Rich Fibrin (P-PRF) (2020-2028) ($MN)
8 Global Platelet Rich Plasma (PRP) Market Outlook, By Pure Platelet Rich Plasma (P-PRP) (2020-2028) ($MN)
9 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Rich Platelet Rich Fibrin (L-PRF) (2020-2028) ($MN)
10 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet-Rich Plasma Instruments (2020-2028) ($MN)
11 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte Rich Platelet Rich Plasma (L-PRP) (2020-2028) ($MN)
12 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet Rich Plasma (PRP) Gel (2020-2028) ($MN)
13 Global Platelet Rich Plasma (PRP) Market Outlook, By Growth Factor Molecules (2020-2028) ($MN)
14 Global Platelet Rich Plasma (PRP) Market Outlook, By Epidermal Growth Factor (EGF) (2020-2028) ($MN)
15 Global Platelet Rich Plasma (PRP) Market Outlook, By Fibroblast Growth Factor-2 (FGF-2) (2020-2028) ($MN)
16 Global Platelet Rich Plasma (PRP) Market Outlook, By Insulin-like Growth Factor (IGF) (2020-2028) ($MN)
17 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2020-2028) ($MN)
18 Global Platelet Rich Plasma (PRP) Market Outlook, By Vascular Endothelial Growth Factor (VEGF) (2020-2028) ($MN)
19 Global Platelet Rich Plasma (PRP) Market Outlook, By Application (2020-2028) ($MN)
20 Global Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2020-2028) ($MN)
21 Global Platelet Rich Plasma (PRP) Market Outlook, By Arthritis (2020-2028) ($MN)
22 Global Platelet Rich Plasma (PRP) Market Outlook, By Chronic Tendinitis (2020-2028) ($MN)
23 Global Platelet Rich Plasma (PRP) Market Outlook, By Bone Repair and Regeneration (2020-2028) ($MN)
24 Global Platelet Rich Plasma (PRP) Market Outlook, By Sports Medicine (2020-2028) ($MN)
25 Global Platelet Rich Plasma (PRP) Market Outlook, By Dermatology & Cosmetic Surgery (2020-2028) ($MN)
26 Global Platelet Rich Plasma (PRP) Market Outlook, By Plastic Surgery (2020-2028) ($MN)
27 Global Platelet Rich Plasma (PRP) Market Outlook, By Androgenic Alopecia/Hair Care (2020-2028) ($MN)
28 Global Platelet Rich Plasma (PRP) Market Outlook, By Ulcer Healing (2020-2028) ($MN)
29 Global Platelet Rich Plasma (PRP) Market Outlook, By Cardiac Muscle Injury (2020-2028) ($MN)
30 Global Platelet Rich Plasma (PRP) Market Outlook, By Ophthalmic Surgery (2020-2028) ($MN)
31 Global Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2020-2028) ($MN)
32 Global Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2020-2028) ($MN)
33 Global Platelet Rich Plasma (PRP) Market Outlook, By Dentistry/Periodontal Surgery (2020-2028) ($MN)
34 Global Platelet Rich Plasma (PRP) Market Outlook, By Aesthetics (2020-2028) ($MN)
35 Global Platelet Rich Plasma (PRP) Market Outlook, By Nerve Injury (2020-2028) ($MN)
36 Global Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2020-2028) ($MN)
37 Global Platelet Rich Plasma (PRP) Market Outlook, By Wound Healing (2020-2028) ($MN)
38 Global Platelet Rich Plasma (PRP) Market Outlook, By Urology (2020-2028) ($MN)
39 Global Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2020-2028) ($MN)
40 Global Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2020-2028) ($MN)
41 Global Platelet Rich Plasma (PRP) Market Outlook, By End User (2020-2028) ($MN)
42 Global Platelet Rich Plasma (PRP) Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
43 Global Platelet Rich Plasma (PRP) Market Outlook, By Hospitals (2020-2028) ($MN)
44 Global Platelet Rich Plasma (PRP) Market Outlook, By Physician's office/Private Practice (2020-2028) ($MN)
45 Global Platelet Rich Plasma (PRP) Market Outlook, By Clinics (2020-2028) ($MN)
46 Global Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic/Dermatology/Trichology Clinics (2020-2028) ($MN)
47 Global Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic Clinics (2020-2028) ($MN)
48 Global Platelet Rich Plasma (PRP) Market Outlook, By Ophthalmic Clinics (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
 

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials